|15.87||+0.25 / +1.60%|
Data as of 4:00pm ET
|15.87||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 29.00, with a high estimate of 50.00 and a low estimate of 20.00. The median estimate represents a +82.73% increase from the last price of 15.87.
The current consensus among 3 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.